Navigation Links
Hospira Launches Piperacillin and Tazobactam for Injection in the United States
Date:10/21/2010

LAKE FOREST, Ill., Oct. 21 /PRNewswire-FirstCall/ -- Hospira, Inc. (NYSE: HSP), the world leader in generic injectable pharmaceuticals, today announced the launch of piperacillin and tazobactam for injection in the United States. The medication is a generic version of Zosyn®, the world's leading injectable antibiotic, from Pfizer (Wyeth). Piperacillin and tazobactam injection posted 2009 U.S. sales of more than $855 million.

Piperacillin and tazobactam for injection is a broad-spectrum antibiotic used to treat patients with moderate to severe infections. It is an injectable combination product that consists of piperacillin (an extended-spectrum penicillin) and tazobactam (a beta-lactamase inhibitor).

"The launch of piperacillin and tazobactam for injection represents another significant generic injectable introduction for Hospira this year, furthering our goal of taking costs out of the healthcare system by providing high-quality, lower-cost alternatives to proprietary medications," said Joshua Gordon, vice president, Specialty Pharmaceuticals, Hospira.

Hospira's piperacillin and tazobactam product portfolio extends beyond the formulations available from the originator. In addition to immediately offering the injectable medication in 2.25 g, 3.375 g and 4.5 g single-dose vials, Hospira will also market the only piperacillin and tazobactam for injection in Hospira's proprietary ADD-Vantage™ system.

The ADD-Vantage ready-to-use drug delivery system from Hospira enhances customer convenience and aids patient safety by eliminating the need for needles. To help hospitals reduce medication errors, Hospira also labels all of its injectable products with unit-of-use bar codes.

Hospira currently markets the piperacillin and tazobactam combination injectables in more than a dozen markets outside the United Sta
'/>"/>

SOURCE Hospira, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Hospira Announces New Contracts in Effect with Novation for Infusion Pumps, Solutions and Equipment
2. Hospira to Host Conference Call for Third-Quarter 2010 Results
3. Hospira Receives TGA Approval for Nivestim™, Australias First Biosimilar Filgrastim
4. Hospira Japan Receives Approval for New Indication for Precedex IV™ 200ug
5. Hospira Announces CEO Succession Plan
6. Hospira to Present at Bank of America Merrill Lynch 2010 Specialty Pharmaceuticals Conference Aug. 12
7. Hospira Begins Phase I U.S. Clinical Trial of Biosimilar Erythropoietin in Renal Patients
8. Hospira TheraDoc(TM) Infection Control Assistant(TM) Documents Interventions to Help Hospital Reduce Catheter-Related Infections
9. Hospira Announces Intention to Complete Tender Offer for Shares of Javelin Pharmaceuticals
10. Hospira Receives FDA Approval for Meropenem for Injection, USP (I.V.)
11. Hospira Announces Further Extension of Tender Offer for Shares of Javelin Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2015)... , June 1, 2015   Royal Philips  (NYSE: ... Magnetic Resonance (MR) solutions to be showcased at the ... 23 rd Annual Meeting & Exhibition in ... Philips booth #301 will see the latest in ... increase clinical performance, enhance patient experience and provide economic ...
(Date:6/1/2015)... June 1, 2015 Novel t ... drive growth , says   GBI Research ... (NSCLC) treatment market will be driven primarily by the introduction ... treatment settings, which either replace or combine with generic chemotherapies. ... Non-Small Cell Lung Cancer Market to 2020 - ...
(Date:6/1/2015)... CEFALY Technology , the creators of ... authorized for use prior to the onset of migraine ... trial showing that the Cefaly device returns normal metabolic ... patients, namely the orbitofrontal cortex and rostral cingulate. ... an imaging test of the brain, used a radioactive substance called a ...
Breaking Medicine Technology:Philips showcases MR research solutions designed to enable collaboration with partners at the ISMRM Annual Meeting 2Philips showcases MR research solutions designed to enable collaboration with partners at the ISMRM Annual Meeting 3New Therapies to Enhance Increasingly Competitive Non-Small Cell Lung Cancer Treatment Market 2New Therapies to Enhance Increasingly Competitive Non-Small Cell Lung Cancer Treatment Market 3New Study Shows CEFALY Returns Normal Metabolic Activity to Brain Areas in Migraine Patients 2
... TAINAN, Taiwan, Aug. 31 /PRNewswire-Asia/ -- ... ... var shortURL = ""; ... we need to grab the first one. for (var r in data.results) { first_result = data.results[r]; break; ...
... ... if (typeof(lpUnit)==,undefined,) var lpUnit=,PRN,; --> ... var shortURL = ""; BitlyCB.alertResponse = function(data) { var s = ... for (var r in data.results) { first_result = data.results[r]; break; } for (var key in first_result) { ...
Cached Medicine Technology:ScinoPharm to Invest in Tanvex Biologics 2ScinoPharm to Invest in Tanvex Biologics 3ScinoPharm to Invest in Tanvex Biologics 4ScinoPharm to Invest in Tanvex Biologics 5ScinoPharm to Invest in Tanvex Biologics 6PharmaVentures Appoints Paul Phull as Senior Director 2PharmaVentures Appoints Paul Phull as Senior Director 3PharmaVentures Appoints Paul Phull as Senior Director 4PharmaVentures Appoints Paul Phull as Senior Director 5PharmaVentures Appoints Paul Phull as Senior Director 6
(Date:6/1/2015)... 2015 "This milestone opens the doors ... previously able to buy and sell shares of our ... and also make recommendations to clients as they so ... to trade shares of our Company,” said Kris Finstad, ... requirements of OTCQB provides our investors greater confidence in ...
(Date:6/1/2015)... Pittsburgh, PA (PRWEB) June 01, 2015 ... this new development in breast cancer prevention. , A ... Health suggests that postmenopausal women with ductal carcinoma in ... cancer treatment and prevention. , The study (NSABP B-35/NRG ... those who completed the standard five-year treatment with tamoxifen ...
(Date:6/1/2015)... For years, facial plastic surgery demands ... like one would request a hairstyle, patients would use ... and more to illustrate their adaptation of choice. However, ... ushering in a new era of aesthetic envy – ... Rizk, MD, FACS notes that since the explosion of ...
(Date:6/1/2015)... There’s never a good time to be sick ... minor illnesses. , As of June 1, OSF HealthCare is ... care via the Internet. Patients throughout Illinois can access care ... “Everyone is busy. We know that getting in to see ... to make it easier,” said Jeffry Tillery, MD, Chief Transformation ...
(Date:6/1/2015)... (PRWEB) June 01, 2015 June 1, ... of clinical journals in the areas of hospital medicine, ... announce that it has expanded upon its partnership with ... Hospital Medicine Practice, in a mobile application format ... tablets. , “We are very excited about the ...
Breaking Medicine News(10 mins):Health News:Content Checked Holdings Inc. Upgrades to the OTCQB Marketplace, now available for trading as CNCK 2Health News:Content Checked Holdings Inc. Upgrades to the OTCQB Marketplace, now available for trading as CNCK 3Health News:Content Checked Holdings Inc. Upgrades to the OTCQB Marketplace, now available for trading as CNCK 4Health News:Today at ASCO: Anastrazole Offers Higher Breast Cancer-Free Survival Rates than Tamoxifen Following DCIS, Phase III Study Shows 2Health News:Today at ASCO: Anastrazole Offers Higher Breast Cancer-Free Survival Rates than Tamoxifen Following DCIS, Phase III Study Shows 3Health News:Instagram Filters Launch New Facial Plastic Surgery Trend 2Health News:OSF HealthCare Now Offering OSF OnCall 2Health News:OSF HealthCare Now Offering OSF OnCall 3Health News:EB Medicine Expands Partnership With AgileMD To Launch Hospital Medicine Mobile Application 2Health News:EB Medicine Expands Partnership With AgileMD To Launch Hospital Medicine Mobile Application 3
... Serena Gordon HealthDay Reporter , WEDNESDAY, May ... the drug lenalidomide can significantly lengthen the time that ... disease, either after having a stem cell transplant or ... studies is whether or not the improved "progression-free" survival ...
... today released a wide-ranging compendium of resources ... and secure sharing of health information. ... Policies in Practice for Health Information Sharingor ... for electronic health information sharing, including informed ...
... Infectious diseasesboth old and newcontinue to exact a devastating ... the world. Vaccines remain the best line of ... Stephen Johnston, researchers at Arizona State University,s Biodesign Institute, ... Texas Southwestern Medical Center are using clever functional screening ...
... -- The rate at which Americans are hospitalized for stroke ... According to the U.S. National Center for Health Statistics (NCHS), ... people during the 1990s but had decreased again to under ... there were still about 800,000 hospitalizations for stroke in 1989 ...
... support and limited pressure to achieve the ,thin and beautiful, ... a new study looking at five factors that may help ... the context of a society where discontent with appearance is ... the University of Arizona in the US, and colleagues is ...
... HealthDay Reporter , TUESDAY, May 8 (HealthDay News) ... atrial fibrillation face a 14 percent greater risk of ... report. The raised risk remained higher even when ... stroke, the study authors noted. "Previously, there was ...
Cached Medicine News:Health News:New Drug Shows Promise for Myeloma Patients 2Health News:New Drug Shows Promise for Myeloma Patients 3Health News:Markle releases new resources for health information sharing implementation 2Health News:Markle releases new resources for health information sharing implementation 3Health News:Advanced genetic screening method may speed vaccine development 2Health News:Advanced genetic screening method may speed vaccine development 3Health News:Advanced genetic screening method may speed vaccine development 4Health News:Rate of Hospitalizations for Stroke Has Declined in U.S. 2Health News:Self-worth needs to go beyond appearance 2Health News:Irregular Heartbeat Poses Greater Stroke Risk for Women Than Men 2
... and VersaStep™ PLUS Reposable system components for creating each ... radial expandable sleeve is packaged sterile together with either ... Insufflation and access needle is packaged non-sterile; 5 ... are packaged non-sterile; 5 mm, 7/8 mm, 10 ...
SURGISPIKE™ Single Use 5 mm Trocar. , ,Bladed Trocars are devices that contain a metal blade to gain access to the abdominal cavity....
... The complete line of Surgical Access ... ,The OnePort™ trocar system is actually ... be versatile, operationally flexible and clinically adaptive ... offering options in disposability and bladed or ...
... line of Surgical Access ...unlike any trocar ... trocar system is actually four systems in ... flexible and clinically adaptive to all of ... disposability and bladed or dilating tip styles, ...
Medicine Products: